Literature DB >> 12787137

Regulation of human epidermal melanocyte biology by beta-endorphin.

Söbia Kauser1, Karin U Schallreuter, Anthony J Thody, Christopher Gummer, Desmond J Tobin.   

Abstract

beta-Endorphin is an opioid peptide cleaved from the precursor pro-hormone pro-opiomelanocortin, from which other peptides such as adrenocorticotropic hormone, beta-lipotropic hormone, and alpha-melanocyte-stimulating hormone are also derived. alpha-Melanocyte-stimulating hormone and adrenocorticotropic hormone are well documented to regulate human skin pigmentation via action at the melanocortin-1 receptor. Whereas plasma beta-endorphin is reported to increase after exposure to ultraviolet radiation, to date a functional role for beta-endorphin in the regulation of human epidermal melanocyte biology has not been demonstrated. This study was designed to examine the involvement of the beta-endorphin/mu-opiate receptor system in human epidermal melanocytes. To address this question we employed reverse transcription-polymerase chain reaction, and immunohistochemistry/cytochemistry and immunoelectron microscopy using beta-endorphin and mu-opiate receptor specific antibodies. A functional role for beta-endorphin was assessed in epidermal melanocyte cultures by direct stimulation with the peptide. This study demonstrated the expression of mu-opiate receptor mRNA in cultured epidermal melanocytes, as well as mRNA for pro-opiomelanocortin. In addition, we have shown that beta-endorphin and mu-opiate receptor are expressed at the protein level in situ in glycoprotein100-positive melanocytes. The expression of both beta-endorphin and mu-opiate receptor correlated positively with their differentiation status in vitro. Furthermore, immunoelectron microscopy studies revealed an association of beta-endorphin with melanosomes. Functional studies showed that beta-endorphin has potent melanogenic, mitogenic, and dendritogenic effects in cultured epidermal melanocytes deprived of any exogenous supply of pro-opiomelanocortin peptides. Thus, we report that human epidermal melanocytes express a fully functioning beta-endorphin/mu-opiate receptor system. In the absence of any data showing cross-talk between the mu-opiate receptor and the melanocortin-1 receptor, we conclude that the beta-endorphin/mu-opiate receptor system participates in the regulation of skin pigmentation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787137     DOI: 10.1046/j.1523-1747.2003.12242.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  25 in total

1.  PGE(2) is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation.

Authors:  Renny J Starner; Lindy McClelland; Zalfa Abdel-Malek; Alex Fricke; Glynis Scott
Journal:  Exp Dermatol       Date:  2010-05-25       Impact factor: 3.960

Review 2.  Melanocyte receptors: clinical implications and therapeutic relevance.

Authors:  J Andrew Carlson; Gerald P Linette; Andrew Aplin; Bernard Ng; Andrzej Slominski
Journal:  Dermatol Clin       Date:  2007-10       Impact factor: 3.478

3.  Dyspigmented hypertrophic scars: Beyond skin color.

Authors:  Abdulnaser Alkhalil; Bonnie C Carney; Taryn E Travis; Seid Muhie; Stacy Ann Miller; Jessica C Ramella-Roman; Pehman Ghassemi; Rasha Hammamieh; Marti Jett; Lauren T Moffatt; Jeffrey W Shupp
Journal:  Pigment Cell Melanoma Res       Date:  2019-04-05       Impact factor: 4.693

4.  Dopamine efflux in response to ultraviolet radiation in addicted sunbed users.

Authors:  Pamela M Aubert; John P Seibyl; Julianne L Price; Thomas S Harris; Francesca M Filbey; Heidi Jacobe; Michael D Devous; Bryon Adinoff
Journal:  Psychiatry Res Neuroimaging       Date:  2016-04-07       Impact factor: 2.376

Review 5.  Emerging role of alternative splicing of CRF1 receptor in CRF signaling.

Authors:  Michał A Zmijewski; Andrzej T Slominski
Journal:  Acta Biochim Pol       Date:  2010-03-16       Impact factor: 2.149

6.  Regulated proenkephalin expression in human skin and cultured skin cells.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Anna A Brozyna; Jackie Granese; Alexander Pisarchik; Andre Szczesniewski; Desmond J Tobin
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

Review 7.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

8.  The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.

Authors:  A Slominski; T-K Kim; A A Brożyna; Z Janjetovic; D L P Brooks; L P Schwab; C Skobowiat; W Jóźwicki; T N Seagroves
Journal:  Arch Biochem Biophys       Date:  2014-07-02       Impact factor: 4.013

9.  Differential expression of a cutaneous corticotropin-releasing hormone system.

Authors:  Andrzej Slominski; Alexander Pisarchik; Desmond J Tobin; Joseph E Mazurkiewicz; Jacobo Wortsman
Journal:  Endocrinology       Date:  2003-11-06       Impact factor: 4.736

10.  The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.

Authors:  D da Fonseca Pacheco; A Klein; A de Castro Perez; C M da Fonseca Pacheco; J N de Francischi; I D G Duarte
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.